Stratec Biomedical AG Share Price Xetra
Equities
DE0007289001
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- EUR | - |
29/04 | STRATEC BIOMEDICAL SYSTEMS AG : Deutsche Bank reiterates its Neutral rating | ZD |
26/04 | STRATEC BIOMEDICAL SYSTEMS AG : Berenberg reiterates its Neutral rating | ZD |
Sales 2024 * | 27Cr 29Cr 2.39TCr | Sales 2025 * | 29Cr 31Cr 2.61TCr | Capitalization | 51Cr 55Cr 4.57TCr |
---|---|---|---|---|---|
Net income 2024 * | 1.6Cr 1.73Cr 144.13Cr | Net income 2025 * | 2.3Cr 2.48Cr 207.18Cr | EV / Sales 2024 * | 2.34 x |
Net Debt 2024 * | 12Cr 13Cr 1.05TCr | Net Debt 2025 * | 7.96Cr 8.59Cr 717.24Cr | EV / Sales 2025 * | 2.02 x |
P/E ratio 2024 * |
31.1
x | P/E ratio 2025 * |
21.8
x | Employees | - |
Yield 2024 * |
2.09% | Yield 2025 * |
2.18% | Free-Float | 59.43% |
Latest transcript on Stratec Biomedical AG
Managers | Title | Age | Since |
---|---|---|---|
Marcus Wolfinger
CEO | Chief Executive Officer | 56 | 01/98/01 |
Robert Siegle
DFI | Director of Finance/CFO | 57 | 01/98/01 |
Jan Keppeler
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Frank Hiller
BRD | Director/Board Member | 58 | 29/19/29 |
Georg Heni
CHM | Chairman | 66 | 20/22/20 |
Rolf Vornhagen
BRD | Director/Board Member | 71 | 21/20/21 |
1st Jan change | Capi. | |
---|---|---|
+11.12% | 23TCr | |
+9.09% | 19TCr | |
+13.03% | 14TCr | |
+25.87% | 11TCr | |
+0.34% | 6.32TCr | |
+11.65% | 5.23TCr | |
+5.62% | 5.1TCr | |
+6.19% | 4.39TCr | |
+4.93% | 3.81TCr |